Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome

Top Cited Papers
Open Access
Abstract
Hypercytokinemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels ≥80 pg×mL−1 predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation
Funding Information
  • Cure Alzheimer's Fund
  • Vancouver Coastal Health Research Institute
  • NIH Clinical Center
  • Weston Brain Institute
  • Canadian Institutes of Health Research